IL17A and arthritic joint disease: Studies of murine models of arthritis are helpful in understanding links between TNF- and IL-17-dependent inflammation and have shown that treating collagen-induced arthritis (CIA) mice with TNF-blocking agents results in a rebound increase in lymph node Th17 cells, with a converse reduction in synovial Th17 cells (Notley et al., 2008).